Recent pharmacovigilance has also identified signals for intestinal obstruction (ileus) with some GLP-1 receptor agonists
Thus, HO-1 plays significant part in regulating the progression and application of DN (Fig
Contact your healthcare provider immediately if you experience: Severe, persistent diarrhea preventing adequate hydration Clinical signs of dehydration (dizziness, dry mouth, dark urine, orthostatic symptoms) Blood in stool or severe abdominal pain Fever accompanying diarrhea Inability to maintain fluid intake due to concurrent vomiting Clinical reports have documented cases of acute kidney injury from severe volume depletion due to excessive diarrhea on GLP-1 therapy
Mean comparison was done by the Kuskal-Wallis test followed by a Mann Whitney test
As we continue to ride the wave of GLP-1 agonists, several vital areas warrant further investigation: Longitudinal studies must assess long-term cognitive outcomes to understand the drugs impact on cognitive function over extended periods
Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: a systematic review
